Merit Medical Systems, Inc.

NasdaqGS MMSI

Merit Medical Systems, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 4.40

Merit Medical Systems, Inc. Price to Sales Ratio (P/S) is 4.40 on January 14, 2025, a 22.05% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Merit Medical Systems, Inc. 52-week high Price to Sales Ratio (P/S) is 4.65 on December 04, 2024, which is 5.67% above the current Price to Sales Ratio (P/S).
  • Merit Medical Systems, Inc. 52-week low Price to Sales Ratio (P/S) is 3.22 on April 18, 2024, which is -26.71% below the current Price to Sales Ratio (P/S).
  • Merit Medical Systems, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 3.93.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
NasdaqGS: MMSI

Merit Medical Systems, Inc.

CEO Mr. Fred P. Lampropoulos
IPO Date May 14, 1990
Location United States
Headquarters 1600 West Merit Parkway
Employees 6,950
Sector Health Care
Industries
Description

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Similar companies

HAE

Haemonetics Corporation

USD 79.96

0.69%

NVST

Envista Holdings Corp

USD 18.85

-0.74%

ATR

AptarGroup, Inc.

USD 154.61

0.47%

COO

The Cooper Companies, Inc.

USD 89.11

-2.38%

TFX

Teleflex Incorporated

USD 179.17

0.35%

WST

West Pharmaceutical Services, Inc.

USD 328.96

-3.13%

RMD

ResMed Inc.

USD 228.83

-0.62%

XRAY

DENTSPLY SIRONA Inc.

USD 18.06

-3.21%

ICUI

ICU Medical, Inc.

USD 161.08

1.85%

ANGO

AngioDynamics, Inc.

USD 11.80

-5.30%

StockViz Staff

January 15, 2025

Any question? Send us an email